KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Enterprise Value (2019 - 2026)

Hims & Hers Health's Enterprise Value history spans 8 years, with the latest figure at -$750.9 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 132.71% to -$750.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$750.9 million, a 132.71% decrease, with the full-year FY2025 number at -$577.5 million, down 92.34% from a year prior.
  • Enterprise Value hit -$750.9 million in Q1 2026 for Hims & Hers Health, down from -$577.5 million in the prior quarter.
  • Over the last five years, Enterprise Value for HIMS hit a ceiling of -$179.6 million in Q4 2022 and a floor of -$1.1 billion in Q2 2025.
  • Historically, Enterprise Value has averaged -$352.8 million across 5 years, with a median of -$221.0 million in 2023.
  • Biggest five-year swings in Enterprise Value: skyrocketed 38.56% in 2022 and later tumbled 403.59% in 2025.
  • Tracing HIMS's Enterprise Value over 5 years: stood at -$179.6 million in 2022, then decreased by 23.02% to -$221.0 million in 2023, then crashed by 35.87% to -$300.3 million in 2024, then crashed by 92.34% to -$577.5 million in 2025, then tumbled by 30.02% to -$750.9 million in 2026.
  • Business Quant data shows Enterprise Value for HIMS at -$750.9 million in Q1 2026, -$577.5 million in Q4 2025, and -$629.7 million in Q3 2025.